Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus

(2021) Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus. Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy. pp. 272-281. ISSN 0102-695X

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

The incidences of diabetes mellitus and other metabolic diseases are increasing worldwide. However, the current treatments for diabetes mellitus and other metabolic diseases are far from being clearly understood. Berberis species from the Barberry family, Berberidaceae, better known as Barberries are widely distributed worldwide. Several extracts and compounds obtained from Berberis species, particularly berberine, revealed effectiveness in the treatment of diabetes mellitus and other metabolic diseases. In the present study, a systematic search in the literature was performed to provide animal and clinical evidences regarding the therapeutic effects of berberine in metabolic diseases and diabetes mellitus. Also, its possible mechanism of action is described, in addition to the reported complication for berberine use and its drug interactions.

Item Type: Article
Keywords: Berberine Metabolic diseases Diabetes mellitus Obesity Insulin resistance telomeric g-quadruplex high-fat diet up-regulation inflammatory responses alkaloids berberine signaling pathway sodium caprate p-glycoprotein protein-kinase cyclosporine-a Pharmacology & Pharmacy
Page Range: pp. 272-281
Journal or Publication Title: Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy
Journal Index: ISI
Volume: 31
Number: 3
Identification Number: https://doi.org/10.1007/s43450-021-00159-0
ISSN: 0102-695X
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/9755

Actions (login required)

View Item View Item